Objectives: The purpose of this study was to screen for genes related to lymph node
metastasis by comparing the differences in the expression profile between pancreatic …

Introduction Pancreatic neuroendocrine tumors (PNETs) in hereditary syndromes pose a
significant challenge to clinicians. The rarity of these syndromes and PNETs itself make it …

Abstract Background/Aim: The neuroendocrine tumor (NET) proliferation-based grading
system (ENETS/WHO) for gastroenteropancreatic (GEP) tumors has proved reliable for …

Pancreatic neuroendocrine tumors (pNETs) are uncommon cancers arising from pancreatic
islet cells. Here we report the analysis of gene mutation, copy number, and RNA expression …

Well-differentiated pancreatic neuroendocrine tumors (PanNETs) comprise∼ 1–3% of
pancreatic neoplasms. Although long considered as reasonably benign lesions, PanNETs …

Pancreatic neuroendocrine neoplasms (pNENs) are rare tumors accounting for only 1%–2%
of all pancreatic tumors. pNENs are pathologically heterogeneous and are categorized into …

To identify prognostic subgroups among nonfunctioning (nonsyndromic) pancreatic
endocrine tumours, a series of 61 tumours were analysed systematically for macroscopic …

Introduction: Little is known about how pancreatic neuroendocrine tumors (PanNETs) evolve
over time and if changes toward a more aggressive biology correlate with prognosis. The …

Prediction for malignancy of pancreatic endocrine tumors (PET) is often a formidable
challenge for the pathologist. The authors evaluated the role of the proliferative activity and …

Background Recent genetic studies have highlighted that alterations in MEN1, chromatin
remodeling genes, and mammalian target of rapamycin (mTOR) pathway genes are the …